Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock

Equities

600866

CNE000000H46

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-04-16 pm EDT 5-day change 1st Jan Change
4.16 CNY +8.62% Intraday chart for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong -3.93% -10.73%
Sales 2021 1.24B 171M Sales 2022 17.49B 2.42B Capitalization 9.85B 1.36B
Net income 2021 106M 14.65M Net income 2022 608M 84.01M EV / Sales 2021 3.85 x
Net Debt 2021 140M 19.33M Net Debt 2022 3.45B 476M EV / Sales 2022 0.76 x
P/E ratio 2021
43.3 x
P/E ratio 2022
11.6 x
Employees 8,908
Yield 2021 *
-
Yield 2022
-
Free-Float 32.79%
More Fundamentals * Assessed data
Dynamic Chart
CJ Cheiljedang Files 20 Million Yuan Patent Case Against Star Lake Bioscience's Unit MT
Guangxin Bio-Intelligent Manufacturing Technology Innovation Co., Ltd. announced that it has received CNY 120 million in funding from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Guangdong Guangxin Innovation Research Institute Co., Ltd. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong cancelled the transaction announced on March 20, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong(XSSC:600866) added to S&P Global BMI Index CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Star Lake Bioscience to Raise $208 Million for Biotech Firm Purchase MT
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guangdong Hardware Mineral Import & Export Group Co., Ltd. signed a share transfer contract to acquire 46.43% stake in Guangdong Star Lake New Material Co., Ltd. from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+8.62%
1 week-3.93%
Current month-3.70%
1 month-3.03%
3 months-6.94%
6 months-18.43%
Current year-10.73%
More quotes
1 week
3.81
Extreme 3.81
4.38
1 month
3.81
Extreme 3.81
4.48
Current year
3.35
Extreme 3.35
4.74
1 year
3.35
Extreme 3.35
6.12
3 years
3.35
Extreme 3.35
9.34
5 years
3.35
Extreme 3.35
9.34
10 years
2.89
Extreme 2.89
9.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 19-09-23
Director of Finance/CFO 49 21-10-14
Director/Board Member 51 23-09-12
Members of the board TitleAgeSince
Director/Board Member 55 13-09-17
Director/Board Member 56 11-01-31
Director of Finance/CFO 48 20-02-13
More insiders
Date Price Change Volume
24-04-17 4.16 +8.62% 13,297,340
24-04-16 3.83 -7.71% 16,553,120
24-04-15 4.15 -2.81% 13,282,950
24-04-12 4.27 -1.84% 6,792,909
24-04-11 4.35 +0.46% 5,518,382

End-of-day quote Shanghai S.E., April 16, 2024

More quotes
STAR LAKE BIOSCIENCE CO., INC. ZHAOQING GUANGDONG is a China-based company principally engaged in the bio-chemical and bio-fermentation business. The Company's principal products are biochemical drugs, feed additives and food additives, including nucleotide additives, amino acid feed additives, nucleoside and nucleotide bulk pharmaceutical chemicals (BPCs), as well as amino acid BPC and intermediates. The Company mainly sells its products in domestic and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600866 Stock